Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
Ortiz MA, Núñez C, Ordóñez D, Alvarez-Cermeño JC, Martínez-Rodriguez JE, Sánchez AJ, Arroyo R, Izquierdo G, Malhotra S, Montalban X, García-Merino A, Munteis E, Alcina A, Comabella M, Matesanz F, Villar LM, Urcelay E. Ortiz MA, et al. Among authors: ordonez d. PLoS One. 2015 Aug 14;10(8):e0134414. doi: 10.1371/journal.pone.0134414. eCollection 2015. PLoS One. 2015. PMID: 26274821 Free PMC article.
Multiple sclerosis associates with LILRA3 deletion in Spanish patients.
Ordóñez D, Sánchez AJ, Martínez-Rodríguez JE, Cisneros E, Ramil E, Romo N, Moraru M, Munteis E, López-Botet M, Roquer J, García-Merino A, Vilches C. Ordóñez D, et al. Genes Immun. 2009 Sep;10(6):579-85. doi: 10.1038/gene.2009.34. Epub 2009 May 7. Genes Immun. 2009. PMID: 19421224
LILRA3 deletion is a genetic risk factor of HIV infection.
Ahrenstorf G, Low HZ, Kniesch K, Ordonez D, Meyer-Olson D, Ahmad F, Kücherer C, Gunsenheimer-Bartmeyer B, Stoll M, Matthias T, Schmidt RE, Witte T. Ahrenstorf G, et al. Among authors: ordonez d. AIDS. 2017 Jan 2;31(1):25-34. doi: 10.1097/QAD.0000000000001304. AIDS. 2017. PMID: 27755104
Donor side effects experienced under minimal controlled ovarian stimulation with in vitro maturation vs. conventional controlled ovarian stimulation for in vitro fertilization treatment.
Marchante M, Barrachina F, Piechota S, Fernandez-González M, Giovannini A, Smith T, Kats S, Paulsen B, González E, Calvente V, Silvan A, Abittan B, Klein J, Klatsky P, Ordonez D, Kramme CC. Marchante M, et al. Among authors: ordonez d. F S Sci. 2024 Aug;5(3):242-251. doi: 10.1016/j.xfss.2024.05.002. Epub 2024 Jun 3. F S Sci. 2024. PMID: 38838957 Free article.
101 results